Podcasts

Episode 2: From Innovation to Impact: The RNA Interference Era Begins

Host

Peter H. Jones, MD, MNLA
Associate Professor
Baylor College of Medicine
Houston, TX

Guest

Bruce D. Given, MD
Chief Medical Scientist
Arrowhead Pharmaceuticals, Inc.
Pasadena, CA

Dr. Bruce Given shares insights into Arrowhead Pharmaceuticals’ innovative approach to siRNA therapeutics and the company’s growing role in lipid management and cardiovascular care. Hosted by Dr. Peter Jones, this conversation highlights the intersection of clinical need and next-gen molecular science.

Sponsored by Arrowhead Pharmaceuticals